Comparison of VSV Pseudovirus and Focus Reduction Neutralization Assays for Measurement of Anti-<i>Andes orthohantavirus</i>Neutralizing Antibodies in Patient Samples

dc.contributor.authorVial, Cecilia
dc.contributor.authorWhitaker, Annalis
dc.contributor.authorWilhelm, Jan
dc.contributor.authorOvalle, Jimena
dc.contributor.authorPerez, Ruth
dc.contributor.authorValdivieso, Francisca
dc.contributor.authorFerres, Marcela
dc.contributor.authorMartinez-Valdebenito, Constanza
dc.contributor.authorEisenhauer, Philip
dc.contributor.authorMertz, Gregory J.
dc.contributor.authorHooper, Jay W.
dc.contributor.authorBotten, Jason W.
dc.contributor.authorVial, Pablo A.
dc.date.accessioned2025-01-23T19:47:48Z
dc.date.available2025-01-23T19:47:48Z
dc.date.issued2020
dc.description.abstractAndes orthohantavirus(ANDV) is the etiologic agent of hantavirus cardiopulmonary syndrome (HCPS), which has a case fatality rate around 35%, with no effective treatment or vaccine available. ANDV neutralizing antibody (NAb) measurements are important for the evaluation of the immune response following infection, vaccination, or passive administration of investigational monoclonal or polyclonal antibodies. The standard assay for NAb measurement is a focus reduction neutralization test (FRNT) featuring live ANDV and must be completed under biosafety level (BSL)-3 conditions. In this study, we compared neutralization assays featuring infectious ANDV or vesicular stomatitis virus (VSV) pseudovirions decorated with ANDV glycoproteins for their ability to measure anti-ANDV NAbs from patient samples. Our studies demonstrate that VSV pseudovirions effectively measure NAb from clinical samples and have greater sensitivity compared to FRNT with live ANDV. Importantly, the pseudovirus assay requires less labor and sample materials and can be conducted at BSL-2.
dc.fuente.origenWOS
dc.identifier.doi10.3389/fcimb.2020.00444
dc.identifier.issn2235-2988
dc.identifier.urihttps://doi.org/10.3389/fcimb.2020.00444
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/100410
dc.identifier.wosidWOS:000576411700001
dc.language.isoen
dc.revistaFrontiers in cellular and infection microbiology
dc.rightsacceso restringido
dc.subjectAndes orthohantavirus(ANDV)
dc.subjecthantavirus cardiopulmonary syndrome (HCPS)
dc.subjectorthohantavirus
dc.subjectvesicular stomatitis virus (VSV) pseudovirus
dc.subjectneutralizing antibodies
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleComparison of VSV Pseudovirus and Focus Reduction Neutralization Assays for Measurement of Anti-<i>Andes orthohantavirus</i>Neutralizing Antibodies in Patient Samples
dc.typeartículo
dc.volumen10
sipa.indexWOS
sipa.trazabilidadWOS;2025-01-12
Files